Lataa...
A Double Blind, Placebo- controlled Trial of Rosiglitazone for Clozapine induced Glucose Metabolism Impairment in patients with Schizophrenia
OBJECTIVE: The primary purpose of this eight week double blind, placebo-controlled trial of rosiglitazone 4 mg/day was to examine its effect on insulin sensitivity index (SI) and glucose utilization (SG) in clozapine-treated schizophrenia subjects with insulin resistance. METHODS: Eighteen subjects...
Tallennettuna:
| Julkaisussa: | Acta Psychiatr Scand |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4296018/ https://ncbi.nlm.nih.gov/pubmed/19183127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-0447.2008.01325.x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|